International Clinical Trial: A Study Comparing Two Medicines, Lumateperone and Olanzapine, in People Experiencing Schizophrenia for the First Time

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117349) titled 'A Study Comparing Two Medicines, Lumateperone and Olanzapine, in People Experiencing Schizophrenia for the First Time' on Sept. 9.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Alternation Blinding and masking:Participant and Outcome Assessor Blinded

Primary Sponsor: Central Institute of Psychiatry

Condition: Health Condition 1: F203- Undifferentiated schizophrenia Health Condition 2: F200- Paranoid schizophrenia Health Condition 3: F201- Disorga...